A liquid chromatography-diode array detection-electrospray ionization mass spectrometric (HPLC-PDA-ESI/MS/MS) method was used for the analysis of the phenolic composition of the ethanolic extract obtained from the leaves of Pleiogynium timorense (DC.) Leenh. Twenty compounds were detected and tentatively characterized. In addition, further phytochemical investigations of the extract resulted in the isolation of twelve major phenolic compounds. Evidence of the structures of these compounds was obtained based on the interpretation of the UV, 1 H NMR, 13 C NMR and DQF-COSY spectral data. The antioxidant effect of the ethanolic extract was examined in vitro using 1,1-diphenyl-2-picrylhydrazyl (DPPH · ) and super oxide anion radical scavenging assays. DPPH · radical scavenging activity was observed for the extract, with an IC 50 of 21.9 µg/mL, while its super oxide anion scavenging activity was less pronounced, with an IC 50 of 123.5 µg/mL The ethanolic extract showed significant hypoglycemic, antioxidant and anti-inflammatory properties. This study suggests that the ethanolic extract of Pleiogynium timorense is a potential source of antioxidant compounds, relatively non-toxic, and have possible beneficial health effects.
There is now increasing evidence to suggest that many chronic diseases, such as cancer, inflammation, arthritis, and diabetes, are the result of cellular damage by free radicals, and antioxidants from natural sources could have a potential role in preventing such diseases [5, 6] .
The current work was addressed to evaluate the antioxidant, hypoglycemic and anti-inflammatory properties of P. timorense leaf extract, and to determine the chemical composition of the extract responsible for the bioactivity.
Fractionation of part of the ethanolic extract of the leaves of P. timorense using silica gel column chromatography resulted in 4 major fractions. The fractions were further subjected to repeated column chromatography using Sephadex LH-20 and polyamide 6S, followed by preparative paper chromatographic separation, to give 12 compounds. The isolated compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) gave chromatographic and spectral data typical for kaempferol (1) [7] , gallic acid (2) [8] , kaempferol-3-O-β-D-galactopyranoside (3) [9] , kaempferol-3-O-β-D-glucopyranoside The molecular formula was suggested based on the isotopic pattern recognitions. (11) [15] , and 1,3,4,6-tetra-O-galloyl-β-D-glucopyranose (12) [16] . Evidence for the structures of these compounds was obtained based on the interpretation of their UV, 1 H NMR and 13 C NMR spectral data (Supplementary information: Tables 1,2). Confirmation of the structures of compounds 11 and 12 was achieved by tracing their homonuclear chemical shift correlation (DQF-COSY).
The antioxidant activity of P. timorense ethanol extract was evaluated using DPPH · and super oxide anion radical scavenging assays. DPPH · radical scavenging activity was observed for the extract, with an IC 50 of 21.9 µg/mL, which was close to that produced by the reference compound (gallic acid). The extract was shown to have super oxide anion scavenging activity, with an IC 50 of 123.5 µg/mL ( Table 2 ). The lethal dose (LD 50 ) of the extract was found to be 3.2 g / kg body weight. This dose was regarded as a guide for other in vivo tests. The ethanolic extract at doses of 50 and 100 mg/kg b. wt, administered one hour before the injection of carrageenan, induced significant and dose dependent anti-inflammatory activity when compared with the control group. The anti-inflammatory activity produced by the higher dose approached that produced by the reference drug indomethacin ( Table 3 ).
The ethanolic extract of P. timorense leaves revealed a significant hypoglycemic activity at a dose of 100 mg/ kg b.wt. The hypoglycemic activity of the extract administered for 8 weeks approached that produced by metformin after 4 weeks of administration ( The extract demonstrated a significant antioxidant activity at a dose of 100 mg/ kg b. wt.. The antioxidant activity was assessed in diabetic rats by measuring blood glutathione level, which reflected the oxidative stress present in diabetes. The decrease in blood glutathione level was 9.8 % in the case of the diabetic group treated with the extract, while that treated with the reference drug (Vitamin E) showed a decrease of 3.8 %; the results were significant when compared with the control group. The non-treated diabetic group showed 38.2 % decrease in blood glutathione level, which indicated high oxidative stress ( Table 5 ). These results indicated that the extract can reduce the oxidative stress present in diabetes.
The antioxidant activity of the ethanolic extract of P. timorense may be attributed to the presence of a variety of phenolic compounds in quite high concentration.
These include flavonol glycosides, flavonol aglycones, phenolic acids and hydrolysable tannins. All of these natural metabolites have been reported to have high free-radical scavenging activity [5, 6] . The combination of these phenolic compounds may contribute to the overall antioxidant activity of the extract. It is well known that the antioxidant activity of plant chemicals is responsible for their protective activity against inflammatory diseases, cancer, cardiovascular diseases and diabetes. The previous results indicated that the ethanolic extract of P. timorense is a potential source of antioxidant compounds. This finding, and relatively the non-toxic nature of the extract, is important from a nutritional point of view, because the extract may induce beneficial health effects due to its high antioxidant properties, and thus may be used as a dietary supplement for the prevention of chronic diseases. Further testing is required to determine the toxicity, bioavailability and in vivo bioactivity of P. timorense total extract as well as its isolated compounds.
Experimental
General: NMR spectra were recorded using a Varian Mercury VX-300 NMR spectrometer. 1 
Plant extraction and fractionation:
Two kg of powdered leaves were defatted with n-hexane (3 L), and then extracted with bi-distilled absolute ethanol (12 L), and the solvent was evaporated under reduced pressure to give a dry brown powder (150 g). Fifty g of the ethanolic extract was subjected to silica gel column chromatography, eluting first with n-hexane: EtOAc (9: 1) then increasing the polarity with EtOAc, followed by EtOAc: EtOH mixtures of increasing polarity. Fractions (250 mL each) were collected. Similar fractions were pooled together and dried in vacuo to give 4 main fractions (I-IV). using water-saturated n-butanol to give compound 1. Fraction II (3.1 g) was chromatographed over Sephadex LH-20 column and eluted with water-saturated n-butanol to give 11 sub-fractions. Fraction 9 was subjected to preparative paper chromatographic analysis on Whatman paper No. 3 MM, using 6% acetic acid as a developing system; the eluted material was dried in vacuo at 40° C to give compound 2. Fraction III (10 g) was applied to a Sephadex LH-20 column and eluted with water-saturated n-butanol followed by methanol to yield 4 sub-fractions. Repeated PC of sub-fraction 1 (400 mg) resulted in the isolation of compounds 3-5. 
Sample preparation for LC/ESI-MS/MS:
Part of the ethanolic extract was dissolved in 20%MeOH (20 mg/mL) and the solution was filtered through 0.45 μm membranes. 
Analysis of the phenolic composition by LC/ESI-MS/MS

Superoxide anion radical scavenging activity:
Superoxide anion scavenging activity of the extract was determined using the previous method [17] with some modifications. Superoxide radicals were generated in the PMS-NADH system and assayed by the reduction of NBT. Test solution (60 μL), 60 μL of 677 μM NADH solution, 60 μL of 144 μM NBT solution and 60 μL of 60 μM PMS solution in 0.1M phosphate buffer, pH 7.4, were added to a microwell plate and incubated at room temperature for 5 min. The absorbance was read at 550 nm. IC 50 values were calculated as before. L-ascorbic acid was used as a positive control. The assay was conducted in triplicates and repeated at least 3 times.
Determination of total phenols: Total phenolics were determined according to the previous method [18] , with some modifications. Fifty μL of the methanolic solution of the extract was added to 100 μL of methanol and mixed with 100 μL of Folin-Ciocalteu reagent. The mixture was shaken and allowed to stand at room temperature for 3 min before the addition of 500 μL of 20% Na 2 CO 3 . The solution was mixed thoroughly and the absorbance was measured at 730 nm after 2 h. Results were expressed as gallic acid equivalents per g of extract from a calibration curve of gallic acid (0-500 μg/mL).
Total flavonoid content:
Flavonoid content was determined according to a reported method [19] . Quercetin was used as a standard. An aliquot of either the methanolic solution of the extract or standard solution was mixed with an equal volume of AlCl 3 .6H 2 O (0.2%).
Absorbance was measured at 367 nm. Results were expressed as mg of quercetin equivalents per g of extract from a calibration curve of the standard (0-500 μg/mL).
Pharmacological tests
Experimental animals and treatment protocol: Albino mice (25-30 g body weight) were used for the determination of lethal dose, while adult male albino rats (Sprague Dawley strain), weighing 130-150 g were used for the other tests according to the reported method [20] . The animals were kept under the same hygienic conditions and on a standard laboratory diet. Animals were housed in cages with good ventilation and illumination and had access to unlimited water and standard rodent chow. Animal maintenance and treatments were conducted in accordance with the National Institute of Health Guide for Animal, as approved by the Institutional Animal Care and Use Committee (IACUC). Doses of the extract and drugs used were calculated according to previously used methodology [20] and were administered orally by gastric tubes.
Lethal dose determination (LD 50 ):
Determination of the LD 50 of the ethanolic extract of P. timorense was estimated according to the method described by Karber [21] . Preliminary experiments were undertaken to determine the minimal dose that kills all animals (LD 100 ) and the maximal dose that fails to kill any animal. Several doses at equal logarithmic intervals were chosen in between these two doses. Each dose was administered orally to a group of 6 animals. The mice were then observed for 24 h and symptoms of toxicity and mortality rates in each group were recorded.
Acute anti-inflammatory assay:
The method of Winter et al. was used [22] . Twenty-four male albino rats, weighing 130-150 g were divided into 4 groups, each with 6 animals. In the first group, the rats received 1 mL of saline and served as the control. In the second group, the rats received 50 mg/kg of the plant extract, and in the third group 100 mg /kg of the plant extract. The animals in the fourth group received 20 mg/kg of the reference drug indomethacin. One h later, all the animals received a sub-plantar injection in the right hind paw of 0.1 mL of 1% carrageenan solution in saline and 0.1 mL saline in the left hind paw. Four h after drug administration, the rats were sacrificed; both hind paws were excised and weighed separately.
